Prone or Supine Extubation in Lomber Spinal Surgery

Status Completed

Clinical Trial Summary

The aim of this study was to investigate the emergence quality of patients extubated on prone or supine position after lumbar spinal surgery. 60 patients with ASA I-II who underwent lumbar spinal surgery between 18-65 years of age were included in the study. Patients with difficult intubation, BMI> 35kg / m2, asthma and reactive airway problems, cardiovascular disease and obstructive sleep apnea will not be included in the study. Initial data will be recorded after standard monitorization. Induction is made by 2 mg / kg propofol, 1 mg / kg fentanyl and 0.5 mg / kg rocuronium will be added for muscle relaxation. Patients with adequate muscle relaxation will be intubated with appropriate endotracheal tube and mechanical ventilation will be initiated. Patients who are then given prone positions on the operating table will be supported with side gels. The head will be placed in the face gel in a neutral position. For intraoperative analgesia, remifentanil infusion at 0.2mcg / kg / min will be applied. After laminectomy is completed and control of bleeding, 1 mg / kg Tramalol and 2 mg / kg Metaclopromide will be applied to all patients. At the end of the skin stitching, the inhalation agent will be closed and the fresh gas will be turned 6 lt 100% O2. Patients who want to be extubated in the prone position are left in this position while the other patients will be placed on the stretcher in a supine position for a short time. Patients will be decurarized be neostigmin with atropine. Extubation will be performed in both positions when spontanous ventilation begins at a tidal volume of 6ml / kg and a frequency of 12-20 / min. All the measures will be taken to ensure airway safety while the patient is extubated pron. The stretcher will be brought to the side of the operating table, investigator will be ready for reintubation and all the necessary persons will be with the patient. Aspiration frequency will be recorded for each patient. During recovery after extubation, the severity of cough will be evaluated as mild (only once), less (more than one but not continuous) and severe (continuously for 5 seconds). Aldrate scores of patient will be recorded and first 9-10 time is estimated from extubation time. Vomiting, nausea, respiratory insufficiency, inability to control the airway and obvious desaturation if seen are also recorded.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03891745
Study type	Observational
Source	Istanbul Medeniyet University
Contact
Status	Completed
Phase
Start date	November 1, 2018
Completion date	October 1, 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04795284` - Biomechanical Parameters of Gait in Patients With Symptomatic Lumbar Spinal Stenosis and Healthy Elderly.
Recruiting	`NCT04066296` - Outcomes for Lumbar Decompressions With Use of Liposomal Bupivicaine	Phase 2
Active, not recruiting	`NCT05114135` - TLIF Osteo3 ZP Putty Study (Also Known as the TOP Fusion Study)	N/A
Recruiting	`NCT06057428` - Activity Levels Amongst Patients With Lumbar Spinal Stenosis
Recruiting	`NCT06075862` - Balance Amongst Patients With Lumbar Spinal Stenosis
Recruiting	`NCT05527145` - Spinal Stenosis and Listhesis Treated With Percutaneous Interspinous Spacer: a Non-surgical Trial	N/A
Recruiting	`NCT01902979` - The Spinal Stenosis Pedometer and Nutrition e-Health Lifestyle Intervention (SSPANLI) Trial	N/A
Completed	`NCT00749073` - The Vertos MILD™ Preliminary Patient Evaluation Study	N/A
Completed	`NCT00527527` - Chiropractic Dosage for Lumbar Stenosis	Phase 2
Completed	`NCT00405691` - Safety and Effectiveness Study of the TOPS System, a Total Posterior Arthroplasty Implant Designed to Alleviate Pain Resulting From Moderate to Severe Lumbar Stenosis	Phase 3
Completed	`NCT03194607` - Quantitative Evaluation of Motor Function Before and After Surgery for Degenerative Lumbar Spinal Stenosis
Recruiting	`NCT06034405` - Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
Completed	`NCT06079580` - Patients With Lumbar Spinal Stenosis With Balance Disorder
Recruiting	`NCT05523388` - Role of Spinal Load in the Pathophysiology of Lumbar Spinal Stenosis
Completed	`NCT04587401` - The Effects of Anesthesia on Cerebral Perfusion in Patients With High Blood Pressure	N/A
Completed	`NCT04563793` - Postmarket Outcomes Study for Evaluation of the Superion™ Spacer
Suspended	`NCT03381677` - Pedicle Osteotomy for Stenosis Trial	N/A
Completed	`NCT02258672` - Preoperative Rehabilitation for Patients Undergoing Surgery for Lumbar Spinal Stenosis	N/A
Completed	`NCT02260401` - Long Term Outcomes of Lumbar Epidural Steroid Injections for Spinal Stenosis	N/A
Completed	`NCT01994512` - Swedish Spinal Stenosis Study	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.